Drug Discovery & Development

Strategies & Technologies Driving Drug Discovery to Market

Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

pH Measurement System

March 12, 2009 6:12 am | Product Releases | Comments

Sensorin’s continuously self-calibrating pH measurement system will be previewed at Interphex 2009.

Aspirin Improves Survival in Women with Stable Heart Disease

March 12, 2009 5:19 am | News | Comments

New results from the Women’s Health Initiative (WHI) Observational Study provide additional evidence that aspirin may reduce the risk of death in postmenopausal women who have heart disease or who have had a stroke.

TOPICS:

Well-Known Enzyme Is Unexpected Contributor to Brain Growth

March 12, 2009 5:02 am | News | Comments

An enzyme researchers have studied for years because of its potential connections to cancer, diabetes, heart disease, hypertension, and stroke appears to have yet another major role to play: helping create and maintain the brain.

TOPICS:
Advertisement

Some States Push Back Against Stem Cell Research

March 12, 2009 4:51 am | by Shannon McCaffrey, Associated Press Writer | News | Comments

A showdown is shaping up in some of the nation's most conservative states over embryonic stem cell research.

TOPICS:

Gilead Sciences Agrees to Acquire CV Therapeutics

March 12, 2009 4:39 am | News | Comments

Gilead Sciences and CV Therapeutics announced the signing of a definitive agreement pursuant to which Gilead will acquire CV Therapeutics for $20.00 per share in cash through a tender offer and second step merger.

TOPICS:

Roche To Take Over Genentech for $46.8 Billion

March 12, 2009 4:28 am | by Alexander G. Higgins, Associated Press Writer | News | Comments

Swiss pharmaceutical giant Roche said it has agreed to buy California-based Genentech for $46.8 billion in a takeover described as the largest in Swiss corporate history.

TOPICS:

Roche and Genentech Reach Friendly Agreement

March 12, 2009 4:16 am | News | Comments

Roche and Genentech announced that they signed a merger agreement under which Roche will acquire the outstanding publicly held interest in Genentech for US $95.00 per share in cash.

TOPICS:

Ex-NYC Health Commissioner Tapped for FDA

March 12, 2009 4:07 am | by Lauran Neergaard and Erica Werner, Associated Press Writers | News | Comments

President Barack Obama intends to name former New York City Health Commissioner Margaret Hamburg to lead the troubled Food and Drug Administration.

TOPICS:
Advertisement

High Content Application

March 11, 2009 12:08 pm | Product Releases | Comments

Thermo Fisher Scientific will unveil the Thermo Scientific Cellomics Comet v3.0 BioApplication on booth #1663 at the SOT 48th Annual Meeting and ToxExpo.

TOPICS:

Lawmakers Introduce Biogenerics Bill

March 11, 2009 11:04 am | by Associated Press | News | Comments

A bipartisan group in Congress wants to give the Food and Drug Administration power to approve copies of costly biotech drugs.

TOPICS:

Environmentally Friendly Workstations

March 11, 2009 7:44 am | Product Releases | Comments

Thermo Fisher Scientific introduced the Thermo Scientific Hamilton Distinction II Adaptable Laboratory Furniture System at Pittcon 2009.

Raman Materials Characterization Software

March 11, 2009 7:27 am | Product Releases | Comments

Thermo Fisher Scientific launched the Thermo Scientific OMNIC Specta software for Raman applications.

TOPICS:

Pathway Discovered That Regulates Inflammation

March 11, 2009 7:02 am | News | Comments

Researchers at the University of Illinois have identified a novel pathway that controls the activity of a key protein involved in inflammation.

TOPICS:

Prana’s PBT2 Prevents Synaptic Loss In Alzheimer’s Disease

March 11, 2009 6:51 am | News | Comments

Prana Biotechnology Limited announced that its lead compound for the treatment of Alzheimer’s Disease, PBT2, prevents the loss of synapses (the space) between neurons that underlies the process of neurodegeneration in Alzheimer’s Disease.

TOPICS:

Drugs That Act On 'Fasting Signal' May Curb Insulin Resistance In Obese

March 11, 2009 6:44 am | News | Comments

A molecular switch found in the fat tissue of obese mice is a critical factor in the development of insulin resistance, report scientists at the Salk Institute for Biological Studies.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading